NCT01896726View on ClinicalTrials.gov

A Study of Baricitinib and Birth Control Pills in Healthy Females

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Healthy Volunteers
Interventions
DRUG

Baricitinib

Administered orally

DRUG

Microgynon

Administered orally

Trial Locations (1)

LS2 9LH

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Leeds

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01896726 - A Study of Baricitinib and Birth Control Pills in Healthy Females | Biotech Hunter | Biotech Hunter